Allspring Global Investments
MRNA icon

Allspring Global Investments’s Moderna MRNA Stock Holding History

Allspring Global Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Buy
23,274
+1,069
+5% +$55.3K ﹤0.01% 1102
2026
Q1 		$1.11M Sell
22,205
-563
-2% -$26.3K ﹤0.01% 1158
2025
Q4 		$703K Buy
22,768
+7,280
+47% +$198K ﹤0.01% 1268
2025
Q3 		$427K Sell
15,488
-2,966
-16% -$82.7K ﹤0.01% 1392
2025
Q2 		$529K Buy
18,454
+3,074
+20% +$81K ﹤0.01% 1326
2025
Q1 		$418K Buy
15,380
+12
+0.1% +$426 ﹤0.01% 1494
2024
Q4 		$645K Sell
15,368
-2,141
-12% -$102K ﹤0.01% 1386
2024
Q3 		$1.17M Sell
17,509
-1,080
-6% -$99.2K ﹤0.01% 1295
2024
Q2 		$2.21M Buy
18,589
+256
+1% +$32.4K ﹤0.01% 1149
2024
Q1 		$1.95M Sell
18,333
-25,912
-59% -$2.61M ﹤0.01% 1189
2023
Q4 		$4.4M Sell
44,245
-4,850
-10% -$408K 0.01% 985
2023
Q3 		$5.07M Sell
49,095
-2,934
-6% -$327K 0.01% 969
2023
Q2 		$6.32M Sell
52,029
-7,084
-12% -$945K 0.01% 933
2023
Q1 		$9.08M Sell
59,113
-3,971
-6% -$655K 0.02% 810
2022
Q4 		$11.3M Sell
63,084
-10,708
-15% -$1.75M 0.02% 746
2022
Q3 		$8.72M Sell
73,792
-10,059
-12% -$1.53M 0.02% 812
2022
Q2 		$12M Sell
83,851
-35,455
-30% -$5.07M 0.02% 730
2022
Q1 		$20.6M Buy
119,306
+15,787
+15% +$2.66M 0.03% 657
2021
Q4 		$26.3M Buy
+103,519
New +$30.3M 0.03% 621

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Allspring Global Investments's MRNA Position: Q2 2026 in Review

Allspring Global Investments increased its Moderna (MRNA) stake by 4.8% in Q2 2026, buying an estimated $55.3K and bringing the position to 23,274 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Allspring Global Investments first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $26.3M in Q4 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Allspring Global Investments held 23,274 shares of Moderna worth $1.69M as of Q2 2026.
  • Allspring Global Investments bought 1,069 Moderna shares in Q2 2026, an estimated $55.3K.
  • Moderna made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1102 holding.
  • Allspring Global Investments first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Moderna position peaked at $26.3M in Q4 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.